US Stock MarketDetailed Quotes

EDIT Editas Medicine

Watchlist
  • 4.205
  • +0.095+2.31%
Close Aug 8 16:00 ET
  • 4.154
  • -0.051-1.22%
Post 20:02 ET
346.81MMarket Cap-1804P/E (TTM)

Editas Medicine Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-47.41%-57.06M
-39.43%-49.87M
25.47%-132.18M
47.39%-22.24M
26.13%-35.46M
-2.29%-38.71M
27.34%-35.77M
-8.27%-177.35M
-22.24%-42.27M
-17.70%-48M
Net income from continuing operations
-67.80%-67.61M
-26.34%-61.95M
30.49%-153.22M
68.93%-18.87M
19.21%-45.02M
24.63%-40.29M
2.93%-49.04M
-14.51%-220.43M
-46.58%-60.74M
-42.59%-55.73M
Operating gains losses
----
----
----
----
--0
--0
--1.58M
----
----
----
Depreciation and amortization
-7.79%1.42M
-8.74%1.41M
-4.31%6.06M
-7.04%1.47M
-5.61%1.51M
-3.63%1.54M
-0.90%1.54M
25.41%6.34M
4.37%1.58M
34.79%1.6M
Other non cash items
----
----
--1.6M
----
----
----
----
----
----
----
Change In working capital
245.81%6.41M
-24.13%4.8M
-119.50%-1.59M
-167.27%-8.09M
777.31%4.56M
-158.08%-4.4M
153.01%6.33M
138.19%8.18M
555.55%12.02M
103.90%520K
-Change in receivables
100.05%1K
102.77%9.94M
-3.36%-5.04M
-54.53%-7.77M
-122.93%-136K
-410.17%-2.04M
543.71%4.9M
-184.38%-4.88M
-31,306.25%-5.03M
641.25%593K
-Change in prepaid assets
326.19%2.14M
-203.15%-1.61M
-43.80%-197K
-118.02%-968K
-86.83%160K
-17.06%-947K
1,673.74%1.56M
-103.67%-137K
-119.16%-444K
129.58%1.22M
-Change in payables and accrued expense
179.78%3.58M
-577.01%-4.15M
-82.37%2.62M
-89.05%1.5M
1,119.35%4.74M
-176.49%-4.49M
120.66%870K
380.36%14.87M
92.41%13.68M
89.85%-465K
-Change in other current assets
-237.36%-4.17M
-76.95%1.34M
141.67%6.63M
75.70%-4.58M
227.17%2.37M
17.69%3.03M
162.51%5.8M
-309.90%-15.92M
-830.19%-18.84M
-174.25%-1.87M
-Change in other current liabilities
10,012.50%4.85M
89.38%-723K
-131.93%-5.61M
-83.55%3.73M
-346.88%-2.58M
101.65%48K
-111.76%-6.81M
267.41%17.57M
786.66%22.65M
166.69%1.04M
-Change in other working capital
----
----
----
----
----
----
----
85.32%-3.33M
--0
--0
Cash from discontinued investing activities
Operating cash flow
-47.41%-57.06M
-39.43%-49.87M
25.47%-132.18M
47.39%-22.24M
26.13%-35.46M
-2.29%-38.71M
27.34%-35.77M
-8.27%-177.35M
-22.24%-42.27M
-17.70%-48M
Investing cash flow
Cash flow from continuing investing activities
300.20%51.95M
-120.39%-4.75M
-103.27%-3.73M
328.28%62.84M
-215.23%-102.82M
424.39%12.98M
-58.73%23.27M
309.43%114.07M
-20.53%-27.53M
324.97%89.23M
Net PPE purchase and sale
-162.12%-3.49M
-1.68%-1.87M
-15.10%-4.72M
-109.46%-1.31M
61.07%-239K
-117.10%-1.33M
18.15%-1.84M
48.60%-4.1M
78.07%-624K
73.81%-614K
Net investment purchase and sale
287.34%55.45M
-111.45%-2.87M
-99.16%988K
338.43%64.15M
-214.18%-102.58M
522.52%14.32M
-57.17%25.11M
354.18%118.17M
-34.55%-26.9M
340.75%89.84M
Cash from discontinued investing activities
Investing cash flow
300.20%51.95M
-120.39%-4.75M
-103.27%-3.73M
328.28%62.84M
-215.23%-102.82M
424.39%12.98M
-58.73%23.27M
309.43%114.07M
-20.53%-27.53M
324.97%89.23M
Financing cash flow
Cash flow from continuing financing activities
-99.73%322K
192K
9,093.07%118.04M
-16.96%514K
0
31,923.16%117.53M
0
-99.54%1.28M
-41.44%619K
-96.79%80K
Net common stock issuance
----
----
--117.08M
--0
--0
----
----
--0
--0
--0
Proceeds from stock option exercised by employees
-27.80%322K
--192K
-25.23%960K
-16.96%514K
--0
21.53%446K
--0
-96.07%1.28M
-41.38%619K
-96.79%80K
Cash from discontinued financing activities
Financing cash flow
-99.73%322K
--192K
9,093.07%118.04M
-16.96%514K
--0
31,923.16%117.53M
--0
-99.54%1.28M
-41.44%619K
-96.79%80K
Net cash flow
Beginning cash position
-44.99%73.1M
-12.29%127.53M
-29.89%145.4M
-59.73%86.42M
29.67%224.69M
-38.12%132.9M
-29.89%145.4M
44.47%207.4M
-18.65%214.58M
-49.29%173.28M
Current changes in cash
-105.21%-4.79M
-335.37%-54.43M
71.18%-17.87M
159.43%41.11M
-434.79%-138.28M
321.30%91.8M
-269.80%-12.5M
-197.12%-62M
-22.74%-69.18M
152.99%41.3M
End cash Position
-69.60%68.32M
-44.99%73.1M
-12.29%127.53M
-12.29%127.53M
-59.73%86.42M
29.67%224.69M
-38.12%132.9M
-29.89%145.4M
-29.89%145.4M
-18.65%214.58M
Free cash flow
-51.22%-60.56M
-37.59%-51.74M
24.56%-136.9M
45.11%-23.55M
26.57%-35.7M
-4.07%-40.04M
26.94%-37.61M
-5.64%-181.47M
-14.62%-42.9M
-12.73%-48.62M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -47.41%-57.06M-39.43%-49.87M25.47%-132.18M47.39%-22.24M26.13%-35.46M-2.29%-38.71M27.34%-35.77M-8.27%-177.35M-22.24%-42.27M-17.70%-48M
Net income from continuing operations -67.80%-67.61M-26.34%-61.95M30.49%-153.22M68.93%-18.87M19.21%-45.02M24.63%-40.29M2.93%-49.04M-14.51%-220.43M-46.58%-60.74M-42.59%-55.73M
Operating gains losses ------------------0--0--1.58M------------
Depreciation and amortization -7.79%1.42M-8.74%1.41M-4.31%6.06M-7.04%1.47M-5.61%1.51M-3.63%1.54M-0.90%1.54M25.41%6.34M4.37%1.58M34.79%1.6M
Other non cash items ----------1.6M----------------------------
Change In working capital 245.81%6.41M-24.13%4.8M-119.50%-1.59M-167.27%-8.09M777.31%4.56M-158.08%-4.4M153.01%6.33M138.19%8.18M555.55%12.02M103.90%520K
-Change in receivables 100.05%1K102.77%9.94M-3.36%-5.04M-54.53%-7.77M-122.93%-136K-410.17%-2.04M543.71%4.9M-184.38%-4.88M-31,306.25%-5.03M641.25%593K
-Change in prepaid assets 326.19%2.14M-203.15%-1.61M-43.80%-197K-118.02%-968K-86.83%160K-17.06%-947K1,673.74%1.56M-103.67%-137K-119.16%-444K129.58%1.22M
-Change in payables and accrued expense 179.78%3.58M-577.01%-4.15M-82.37%2.62M-89.05%1.5M1,119.35%4.74M-176.49%-4.49M120.66%870K380.36%14.87M92.41%13.68M89.85%-465K
-Change in other current assets -237.36%-4.17M-76.95%1.34M141.67%6.63M75.70%-4.58M227.17%2.37M17.69%3.03M162.51%5.8M-309.90%-15.92M-830.19%-18.84M-174.25%-1.87M
-Change in other current liabilities 10,012.50%4.85M89.38%-723K-131.93%-5.61M-83.55%3.73M-346.88%-2.58M101.65%48K-111.76%-6.81M267.41%17.57M786.66%22.65M166.69%1.04M
-Change in other working capital ----------------------------85.32%-3.33M--0--0
Cash from discontinued investing activities
Operating cash flow -47.41%-57.06M-39.43%-49.87M25.47%-132.18M47.39%-22.24M26.13%-35.46M-2.29%-38.71M27.34%-35.77M-8.27%-177.35M-22.24%-42.27M-17.70%-48M
Investing cash flow
Cash flow from continuing investing activities 300.20%51.95M-120.39%-4.75M-103.27%-3.73M328.28%62.84M-215.23%-102.82M424.39%12.98M-58.73%23.27M309.43%114.07M-20.53%-27.53M324.97%89.23M
Net PPE purchase and sale -162.12%-3.49M-1.68%-1.87M-15.10%-4.72M-109.46%-1.31M61.07%-239K-117.10%-1.33M18.15%-1.84M48.60%-4.1M78.07%-624K73.81%-614K
Net investment purchase and sale 287.34%55.45M-111.45%-2.87M-99.16%988K338.43%64.15M-214.18%-102.58M522.52%14.32M-57.17%25.11M354.18%118.17M-34.55%-26.9M340.75%89.84M
Cash from discontinued investing activities
Investing cash flow 300.20%51.95M-120.39%-4.75M-103.27%-3.73M328.28%62.84M-215.23%-102.82M424.39%12.98M-58.73%23.27M309.43%114.07M-20.53%-27.53M324.97%89.23M
Financing cash flow
Cash flow from continuing financing activities -99.73%322K192K9,093.07%118.04M-16.96%514K031,923.16%117.53M0-99.54%1.28M-41.44%619K-96.79%80K
Net common stock issuance ----------117.08M--0--0----------0--0--0
Proceeds from stock option exercised by employees -27.80%322K--192K-25.23%960K-16.96%514K--021.53%446K--0-96.07%1.28M-41.38%619K-96.79%80K
Cash from discontinued financing activities
Financing cash flow -99.73%322K--192K9,093.07%118.04M-16.96%514K--031,923.16%117.53M--0-99.54%1.28M-41.44%619K-96.79%80K
Net cash flow
Beginning cash position -44.99%73.1M-12.29%127.53M-29.89%145.4M-59.73%86.42M29.67%224.69M-38.12%132.9M-29.89%145.4M44.47%207.4M-18.65%214.58M-49.29%173.28M
Current changes in cash -105.21%-4.79M-335.37%-54.43M71.18%-17.87M159.43%41.11M-434.79%-138.28M321.30%91.8M-269.80%-12.5M-197.12%-62M-22.74%-69.18M152.99%41.3M
End cash Position -69.60%68.32M-44.99%73.1M-12.29%127.53M-12.29%127.53M-59.73%86.42M29.67%224.69M-38.12%132.9M-29.89%145.4M-29.89%145.4M-18.65%214.58M
Free cash flow -51.22%-60.56M-37.59%-51.74M24.56%-136.9M45.11%-23.55M26.57%-35.7M-4.07%-40.04M26.94%-37.61M-5.64%-181.47M-14.62%-42.9M-12.73%-48.62M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion--------Unqualified Opinion----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg